The foundation of Alzheimer’s research cracked in 2022 when neuroscientist Matthew Shrag uncovered doctored Western blots in a landmark 2006 Nature paper by Sylvain Lesné. The image manipulation wasn’t minor - it fabricated evidence for a specific amyloid oligomer said to cause cognitive decline. That paper became a cornerstone of the amyloid cascade hypothesis, which dominated research for decades.
The fraud extended far beyond one study. Investigative journalist Charles Pillar found over 100 papers by NIH official Eliezer Masliah contained similar image irregularities - some stretching back 30 years. Masliah oversaw a $2.7 billion federal budget. When the data is manufactured, the science is over before it begins.
For three decades, the amyloid hypothesis funneled billions into drugs like Aduhelm. They cleared plaques but failed patients. Pillar calls it a hijacking - a monoculture of researchers protecting a failing dogma. Careers, grants, and prestige all depended on amyloid. Alternatives were starved of funding.
Shrag argues the real problem isn’t plaques - it’s the brain’s failure to clear waste. He points to blood vessel health and blood pressure control as more promising paths. Yet NIH and universities suppressed dissent. The University of Minnesota delayed investigating Lesné for years, letting him keep federal funding.
"The most important thing is not to fool yourself - and you are the easiest person to fool."
- Matthew Shrag, Freakonomics Radio
Regulatory capture deepened the crisis. Pillar exposed FDA officials who approved amyloid drugs then took board seats at the same companies. Science became a pipeline for profit, not truth. Whistleblowers were isolated. Shrag found his own mentor, Othman Ghribi, had manipulated images in their joint work - labeled as 'exaggeration' to make results clearer.
"We’ve been chasing a phantom for 30 years while real patients deteriorated."
- Charles Pillar, Freakonomics Radio
The cost is measured in wasted lives and misdirected funding. The amyloid theory didn’t just fail - it actively blocked progress. Now, with the fraud exposed, the field must confront a simple question: how much longer will institutions protect the past instead of pursuing real cures?
